positivesens
singlestrand
rna
virus
ssrna
compris
mani
pathogen
seriou
threat
human
health
virus
affect
million
peopl
worldwid
mani
treatment
avail
human
ssrna
virus
current
larg
impact
public
health
includ
dengu
viru
denv
recent
emerg
virus
chikungunya
viru
chikv
zika
viru
zikv
although
middl
east
respiratori
syndromecoronaviru
merscov
infect
larg
number
peopl
like
aforement
virus
diagnos
patient
die
mer
consid
viru
genet
possibl
chang
increas
transmiss
human
would
mean
seriou
public
health
threat
consid
worth
prepar
gain
insight
pathogenesi
virus
thu
relev
thoroughli
understand
identifi
new
treatment
prevent
option
innat
immun
system
first
line
defenc
invad
pathogen
develop
multipl
mechan
sens
invad
virus
subsequ
signal
transduct
pathway
target
initi
contain
infect
bodi
conserv
microbi
structur
known
pathogenassoci
molecular
pattern
pamp
sens
pattern
recognit
receptor
prr
innat
immun
system
result
activ
downstream
signal
pathway
elicit
effect
antimicrobi
respons
interferon
ifn
key
molecul
respons
three
famili
interferon
type
iii
ifn
regard
main
effector
antivir
innat
respons
mani
differ
cell
type
type
ii
ifn
specif
express
special
immun
cell
involv
modul
adapt
immun
type
iii
ifn
activ
socal
interferonstimul
gene
isg
promot
antivir
state
infect
well
neighbour
cell
restrict
viral
replic
induc
apoptosi
protect
organ
viru
spread
cytolyt
ssrna
virus
outrun
respons
rapid
transmiss
new
host
noncytolyt
ssrna
virus
order
creat
window
opportun
effici
replic
despit
innat
immun
system
develop
multipl
mechan
prevent
ifn
induct
subsequ
signal
activ
viral
innat
immun
evas
strategi
shown
target
prr
downstream
signal
molecul
transcript
factor
ifn
pathway
well
effector
isg
product
addit
major
passiv
way
ssrna
virus
thought
prevent
detect
innat
immun
sensor
hide
viral
replic
intermedi
rearrang
intracellular
membran
socal
replic
organel
factori
one
reason
ssrna
virus
caus
patholog
human
probabl
abil
activ
evad
innat
immun
system
particular
ifn
respons
target
interferon
respons
ssrna
virus
quit
extens
review
strategi
viral
protein
suppress
ifn
signal
thu
well
establish
although
divers
strategi
use
suggest
research
probabl
identifi
yet
differ
evas
mechan
importantli
review
studi
focus
vitro
experi
andor
examin
ectop
express
protein
determin
role
viral
factor
innat
immun
evas
actual
link
host
innat
immun
evas
patholog
observ
viral
infect
gener
receiv
less
attent
therefor
remain
comprehens
investig
order
set
stage
review
discuss
avail
data
latter
subject
discuss
viral
protein
target
innat
immun
emerg
virus
belong
togavirida
coronavirida
flavivirida
famili
summar
avail
knowledg
influenc
viral
activ
pathogenesi
viru
infect
main
focu
review
describ
evas
type
type
iii
ifn
respons
influenc
infect
outcom
base
advanc
studi
conduct
ex
vivo
vivo
viral
infect
type
iii
ifn
rapidli
induc
initi
antivir
state
type
ifn
famili
consist
subtyp
human
one
subtyp
sever
subtyp
poorli
studi
recent
discov
type
iii
ifn
system
consist
trigger
type
iii
ifn
product
downstream
signal
molecul
actual
similar
two
type
howev
type
iii
interferon
preferenti
act
epitheli
cell
provid
antivir
protect
local
thought
caus
less
immunemedi
damag
potent
system
type
ifn
respons
therefor
propos
type
iii
ifn
initi
respons
knock
infect
epitheli
barrier
without
caus
immunopatholog
type
ifn
come
play
first
line
defenc
suffici
control
infect
product
two
type
ifn
initi
innat
immun
system
recogn
invad
virus
prr
three
type
prr
sens
rna
virus
well
describ
tolllik
receptor
tlr
nucleotidebind
oligomer
domain
nod
like
receptor
nlr
retino
acidinduc
gene
rigi
like
receptor
rlr
specif
activ
ifn
respons
rigi
melanoma
differentiationassoci
protein
well
studi
activ
doublestrand
rna
dsrna
upon
activ
signal
trif
tirdomaincontain
adapterinduc
result
induct
follow
four
transcript
factor
activ
protein
nuclear
factor
kappalightchainenhanc
activ
b
cell
interferon
regul
factor
four
transcript
factor
involv
regul
ifn
express
involv
induct
proinflammatori
cytokin
activ
first
two
transcript
factor
achiev
recruit
receptorinteract
protein
tnf
receptorassoci
factor
pathway
ultim
lead
degrad
inhibitor
kb
therebi
releas
activ
two
transcript
factor
achiev
signal
activ
two
kinas
traf
famili
memberassoci
activ
bind
kinas
induc
kinas
activ
phosphoryl
promot
transloc
nucleu
locat
endosom
recogn
ssrna
signal
myeloid
differenti
primari
respons
gene
pathway
form
complex
receptorassoci
kinas
next
complex
activ
transcript
factor
figur
rigi
sens
viral
molecul
cytoplasm
rigi
expos
caspas
activ
recruit
domain
card
upon
bind
short
rna
contain
end
polyuridinerich
sequenc
card
bind
adaptor
protein
mitochondri
antivir
signal
mav
interact
therebi
converg
pathway
bind
rigi
mav
promot
polyubiquitin
card
domain
subsequ
tetrameris
rigi
describ
trigger
phosphoryl
transcript
factor
transloc
nucleu
signal
via
result
activ
figur
thought
trigger
signal
cascad
rigi
except
activ
long
dsrna
irf
essenti
induct
thought
requir
cofactor
express
interferon
earli
stage
viral
infect
mainli
depend
constitut
express
ifn
trigger
transcript
serv
amplifi
ifn
respons
induc
bind
cognat
receptor
induc
express
isg
bind
heterodimer
receptor
consist
subunit
signal
heterodimer
receptor
compos
receptor
remark
receptor
activ
signal
cascad
led
idea
type
iii
ifn
system
might
redund
nonetheless
seem
differ
express
level
kinet
stimul
isg
even
though
system
share
signal
transduct
pathway
bind
type
ifn
type
iii
ifn
receptor
lead
assembl
isg
factor
complex
complex
built
heterodim
signal
transduc
activ
transcript
heterodimer
initi
phosphoryl
janu
kinas
tyrosin
kinas
capabl
bind
ifnstimul
respons
element
isg
promot
result
express
isg
induc
antivir
state
figur
togeth
isg
virtual
act
everi
step
viral
life
cycl
ie
entri
replic
translat
assembl
bud
similar
interferon
regul
express
hundr
gene
regul
gene
involv
recruit
innat
immun
cell
activ
proinflammatori
state
cell
well
activ
differenti
inflammatori
cell
exampl
import
transcript
factor
product
proinflammatori
cytokin
includ
interleukin
tumour
necrosi
factor
chemokin
motif
chemokin
ligand
motif
chemokin
signal
thu
import
mediat
control
viru
infect
also
implic
inflammatori
diseas
human
coronavirus
regard
lowli
pathogen
long
time
howev
recent
discov
sever
acut
respiratori
syndrom
cov
sarscov
merscov
prove
otherwis
sarscov
outbreak
caus
worldwid
epidem
global
casefat
rate
around
merscov
epidem
start
still
ongo
estim
casefat
rate
global
emerg
virus
caus
sever
respiratori
ill
addit
merscov
caus
renal
dysfunct
coronavirus
largest
known
positivestrand
rna
genom
around
kb
termin
cap
poli
tail
end
figur
termin
twothird
genom
encod
two
larg
open
read
frame
orf
express
viral
genom
result
product
two
polypeptid
translat
accomplish
ribosom
frameshift
end
polypeptid
process
two
three
intern
virusencod
proteas
nonstructur
protein
nsp
nsp
involv
replic
viral
genom
subgenom
mrna
synthesi
also
evas
host
innat
immun
remain
onethird
genom
encod
viral
structur
protein
spike
envelop
e
membran
nucleocapsid
n
accessori
protein
accessori
gene
also
implic
antagon
ifn
respons
sarscov
encod
eight
accessori
protein
merscov
encod
five
accessori
protein
ifn
respons
consid
import
control
coronaviru
infect
ifn
treatment
improv
outcom
sarscov
merscov
infect
mice
nonhuman
primat
human
sarscovinfect
patient
therapi
combin
steroid
associ
higher
oxygen
satur
level
faster
improv
lung
abnorm
patient
merscov
infect
treatment
combin
ribavirin
result
improv
surviv
rate
day
diagnosi
howev
effect
present
anymor
day
studi
conclud
benefici
effect
use
ifn
treatment
current
anoth
trial
studi
efficaci
combin
lopinavirritonavir
mer
patient
still
ongo
therefor
actual
proof
efficaci
ifn
treatment
yet
notwithstand
express
level
ifn
diseas
cours
suggest
ifn
import
exampl
studi
macaqu
show
age
macaqu
infect
sarscov
sever
patholog
compar
young
adult
induct
consider
lower
age
anim
two
studi
sar
patient
express
ifn
isg
detect
peripher
blood
mononuclear
cell
deriv
patient
indic
gene
suppress
one
mer
case
fatal
outcom
rigi
downregul
compar
level
ifn
compon
recov
patient
addit
produc
sever
knockout
mice
model
also
illustr
import
ifn
signal
control
coronaviru
infect
mice
complet
defici
type
ii
iii
ifn
signal
suscept
mouseadapt
sarscov
sarscov
urbani
strain
show
sever
patholog
mice
lack
replic
sarscov
lung
enhanc
doubleknockout
mice
viral
titr
lung
even
increas
addit
mice
defici
show
delay
clearanc
lung
remark
doubleknockout
mice
show
differ
clinic
outcom
compar
wildtyp
wt
sarscovinfect
mice
mice
present
sign
diseas
decreas
surviv
would
suggest
increas
replic
sarscov
directli
relat
patholog
diseas
outcom
addit
result
highlight
interferonindepend
signal
pathway
possibl
import
restrict
sarscov
patholog
moreov
mice
defici
trif
show
weight
loss
sever
lung
patholog
due
sarscov
infect
sinc
mice
natur
suscept
merscov
one
way
allow
merscov
infect
transduc
adenoviru
express
human
receptor
transduc
mice
show
increas
bodi
weight
loss
delay
viral
clearanc
increas
inflamm
anim
die
merscov
infect
studi
transduc
mav
mice
infect
merscov
result
consider
weight
loss
group
summari
find
studi
mous
model
suggest
ifn
respons
import
clearanc
control
coronavirus
infect
howev
restrict
viral
replic
alway
seem
directli
associ
clinic
outcom
infect
paradox
also
clear
evid
immunopathogen
role
ifn
coronaviru
infect
innat
immun
respons
particular
elev
level
proinflammatori
cytokin
consid
possibl
contributor
patholog
sar
long
time
high
level
proinflammatori
cytokin
chemokin
detect
sera
sar
patient
anoth
cohort
sar
patient
high
express
level
isg
interferon
gamma
receptor
ifnstimul
chemokin
correl
diseas
sever
especi
upregul
crisi
phase
sar
patient
die
simultan
isg
significantli
downregul
severesar
patient
support
studi
mer
patient
upregul
also
demonstr
serum
mer
subject
pneumonia
correspondingli
kim
et
al
show
mer
patient
correl
sever
diseas
addit
express
delay
moreov
found
associ
sever
diseas
howev
might
mislead
patient
receiv
pegyl
might
affect
detect
associ
controversi
role
ifn
diseas
pathogenesi
also
demonstr
mous
model
one
studi
balbc
mice
infect
sarscov
surviv
diseas
sever
measur
balbc
mice
highli
suscept
mouseadapt
sarscov
infect
lethal
young
mice
infect
result
clear
sign
diseas
mice
consider
weight
loss
mice
die
infect
importantli
studi
show
express
proinflammatori
cytokin
delay
sever
ill
mice
moreov
balbc
ifnar
mice
infect
surviv
mild
moder
weight
loss
diseas
score
line
dediego
et
al
show
inhibit
result
reduc
inflamm
lung
patholog
balbc
mice
infect
togeth
observ
indic
dysregul
andor
delay
ifn
respons
least
partli
respons
patholog
sar
mer
ambigu
ifn
respons
seem
contribut
simultan
protect
virus
patholog
induc
viru
infect
evas
ifn
respons
coronavirus
may
thu
necessarili
lead
sever
patholog
mani
nsp
structur
protein
accessori
protein
encod
coronavirus
suggest
antagon
ifn
respons
interestingli
shown
cell
cultur
merscov
sensit
treatment
sarscov
suggest
sarscov
effect
evad
innat
immun
respons
regard
structur
protein
role
e
protein
pathogenesi
studi
particular
dediego
et
al
demonstr
balbc
mice
infect
lack
e
protein
show
reduc
lung
patholog
suffer
consider
weight
loss
mortal
observ
compar
wildtyp
mice
research
abl
link
reduc
virul
reduc
induct
suggest
pathogenesi
sarscov
close
link
inflammatori
respons
furthermor
addit
studi
show
pathogenesi
caus
sarscov
e
protein
connect
ion
channel
ic
activ
author
claim
ic
activ
could
activ
inflammasom
would
result
damag
immun
respons
accessori
gene
sarscov
implic
antagon
ifn
pathway
accessori
gene
still
unknown
function
howev
convinc
evid
effect
accessori
protein
sarscov
virul
gener
yet
zhao
et
al
show
minim
effect
delet
accessori
protein
virul
sarscov
studi
found
effect
virul
viru
replic
delet
one
accessori
gene
contrast
merscov
accessori
gene
shown
influenc
coronaviru
replic
diseas
outcom
mice
vitro
merscov
lack
gene
show
enhanc
type
iii
ifn
respons
viru
evalu
mous
model
made
suscept
merscov
modul
crispr
mice
merscov
mutant
replic
less
effici
lung
mice
remov
accessori
gene
mouseadapt
merscov
caus
clinic
symptom
prevent
weight
loss
mice
reduc
product
proinflammatori
cytokin
although
effect
ifn
product
describ
author
moreov
use
chimer
mous
hepat
viru
express
merscov
accessori
protein
establish
protein
necessari
optim
replic
viru
primari
mous
bone
marrowderiv
macrophag
bmm
moreov
catalyt
site
mutat
chimer
viru
abl
replic
titr
equival
wildtyp
viru
rnase
bmm
rnase
mice
indic
merscov
counteract
rnasel
pathway
interferoninduc
antivir
pathway
therebi
enhanc
viral
replic
summari
none
sarscov
accessori
protein
link
coronaviru
pathogenesi
yet
contrari
merscov
accessori
protein
implic
major
virul
factor
possibl
counteract
ifninduc
respons
differ
virus
might
complet
surpris
sinc
sequenc
homolog
accessori
gene
howev
surpris
merscov
seem
counteract
innat
immun
respons
way
sarscov
sinc
observ
differ
sensit
ifn
treatment
suggest
sarscov
effect
evad
innat
immun
respons
howev
might
explain
specif
ifn
pathway
target
exampl
sarscov
shown
block
transloc
use
merscov
inhibit
transloc
cell
treat
ng
pegifn
thu
type
pathway
block
differ
coronavirus
might
explain
differ
sensit
ifn
howev
complet
pictur
evas
activ
virus
draw
firm
conclus
mani
coronaviru
nsp
implic
evas
innat
immun
effect
studi
vivo
coronavirus
encod
macrodomain
function
fehr
et
al
creat
sarscov
mutant
lack
macrodomain
activ
infect
balbc
mice
mutant
virus
mice
surviv
significantli
increas
mice
develop
lung
patholog
infect
virus
lack
macrodomain
activ
moreov
found
increas
express
type
ifn
inflammatori
cytokin
tnf
interest
sinc
studi
observ
decreas
proinflammatori
cytokin
surviv
diseas
patholog
improv
remark
infect
ifnar
mice
restor
pathogenesi
mutant
virus
might
suggest
type
iii
ifn
system
possibl
unknown
system
also
play
import
role
sar
pathogenesi
besid
macrodomain
also
contain
papainlik
proteas
plpro
requir
process
coronaviru
nsp
plpro
thought
antagon
ifn
respons
deubiquitin
enzym
dub
activ
allow
proteas
remov
ubiquitin
substrat
ubiquitin
posttransl
modif
among
mani
function
import
regul
innat
immun
pathway
group
recent
test
recombin
merscov
mutant
lack
dub
activ
intact
proteolyt
activ
lethal
mous
model
transgen
mice
express
human
infect
dubneg
merscov
show
significantli
increas
surviv
compar
wt
virusinfect
mice
moreov
level
sever
isg
proinflammatori
cytokin
found
upregul
earlier
time
point
mice
infect
dubneg
merscov
wt
virusinfect
mice
late
induct
innat
immun
respons
wt
virusinfect
mice
reach
outofcontrol
high
level
suggest
dubneg
merscov
less
effect
evad
innat
immun
result
earli
balanc
immun
respons
import
control
infect
delay
innat
immun
induct
caus
dub
function
wt
viru
infect
dysregul
respons
caus
sever
immunopatholog
symptom
unpublish
data
summari
indic
dub
activ
major
contributor
pathogenesi
coronaviru
infect
altogeth
studi
show
sever
mechan
evad
immun
respons
enhanc
patholog
coronavirus
activ
therebi
involv
cap
viral
rna
prevent
detect
innat
immun
sensor
sarscov
mutant
without
activ
use
infect
balbc
mice
comparison
wt
infect
anim
mice
gener
suffer
less
weight
loss
less
pronounc
lung
diseas
surviv
rate
increas
interestingli
viru
attenu
anymor
knockout
mice
interferoninduc
protein
tetratricopeptid
repeat
ifit
famili
knockout
mice
mice
pathogenesi
mutant
viru
complet
restor
suggest
possibl
role
type
iii
ifn
ifit
recogn
unmethyl
rna
might
act
ifnindepend
matter
sar
pathogenesi
moreov
merscov
mutant
lack
activ
show
attenu
replic
primari
human
airway
epitheli
cell
mice
could
attribut
increas
recognit
innat
immun
support
increas
sensit
mutant
type
ifn
vitro
though
direct
effect
viru
replic
exclud
might
also
contribut
attenu
phenotyp
vivo
mutat
highli
lethal
mouseadapt
merscov
rescu
mice
minim
diseas
observ
togeth
studi
implic
import
factor
sar
mer
pathogenesi
pathogenesi
associ
seem
depend
ifit
necessarili
type
ifn
although
test
mous
model
merscov
addit
protein
coronaviru
genom
also
encod
noncod
rna
ncrna
inhibit
small
ncrna
deriv
n
gene
associ
decreas
inflamm
reduc
gross
patholog
lung
though
viral
titer
surviv
influenc
pretreat
mice
inhibitor
ncrnan
lung
balbc
mice
infect
show
increas
express
isg
decreas
express
proinflammatori
cytokin
like
studi
therebi
support
view
dysregul
ifn
respons
increas
inflamm
partli
due
immun
evas
activ
viru
respons
lung
patholog
observ
coronaviru
infect
chikungunya
viru
alphaviru
member
togavirida
famili
caus
fever
skin
rash
sever
joint
pain
symptom
resolv
within
week
arthralgia
recurr
case
persist
month
year
viru
transmit
human
aed
mosquito
current
mainli
affect
individu
america
alphavirus
genom
around
contain
termin
cap
termin
poli
tail
figur
genom
consist
two
orf
termin
orf
encod
nonstructur
protein
termin
orf
encod
structur
protein
consequ
two
polyprotein
produc
cleav
viral
host
proteas
four
nonstructur
protein
nsp
five
structur
protein
c
nsp
express
genom
rna
involv
viral
replic
structur
protein
express
subgenom
rna
essenti
compon
new
viral
particl
ifn
respons
also
implic
control
chikv
infect
patient
infect
chikv
high
serum
level
express
level
posit
correl
viral
load
besid
chikungunya
patient
also
mice
nonhuman
primat
high
level
type
ifn
blood
chikv
infect
howev
strike
differ
immun
profil
found
patient
phase
chikv
infect
acut
phase
sever
proinflammatori
cytokin
chemokin
peak
earli
convalesc
phase
cell
cytokin
mainli
detect
chronic
phase
proinflammatori
cytokin
produc
cell
significantli
upregul
patient
persist
joint
pain
thu
sever
diseas
high
level
detect
moreov
teng
et
al
perform
metaanalysi
demonstr
common
express
profil
ifn
proinflammatori
cytokin
found
acut
phase
chikv
infect
patient
cohort
overal
studi
indic
respons
chikv
infect
ifn
system
rapidli
activ
treatment
infect
mice
chikv
decreas
viremia
diseas
sign
howev
treat
mice
day
infect
result
therapeut
effect
suggest
acut
phase
antivir
respons
activ
chikv
involv
control
chikv
infect
later
phase
respons
might
effect
could
due
ifn
respons
normal
shut
later
phase
chikv
alreadi
dissemin
caus
patholog
thu
need
differ
kind
immun
respons
control
infect
addit
ifn
respons
may
normal
effect
evad
chikv
earli
stage
infect
pretreat
may
overrul
evas
moreov
studi
age
macaqu
show
chikv
infect
persist
elderli
anim
link
reduc
isg
respons
rhesu
macaqu
fibroblast
stimul
sera
age
macaqu
collect
post
infect
produc
lower
level
isg
stimul
sera
younger
adult
anim
contrari
persist
inflammatori
respons
could
also
contribut
pathogenesi
chikungunya
demonstr
high
level
proinflammatori
cytokin
chemokin
patient
persist
joint
pain
addit
cellular
immun
compon
macrophag
cell
also
implic
immunopatholog
diseas
role
innat
immun
chikv
infect
extens
studi
experiment
anim
model
primari
fibroblast
isol
wt
mice
show
replic
chikv
increas
cell
interestingli
high
level
type
ifn
express
fibroblast
suggest
prr
activ
ifn
respons
although
suffici
control
replic
sinc
replic
enhanc
cell
mice
viral
load
increas
inflamm
sever
viru
could
dissemin
extens
support
anoth
studi
found
trif
mice
increas
viral
load
inflamm
foot
swell
compar
wt
mice
infect
chikv
howev
conflict
result
obtain
mice
studi
schilt
et
al
author
observ
chang
viral
load
tissu
blood
though
et
al
suggest
might
relat
methodolog
differ
age
mice
inject
rout
use
furthermor
chikv
infect
lethal
wt
immunocompet
mice
howev
ifnar
stat
mice
succumb
infect
patholog
sever
suggest
import
role
ifn
chikv
pathogenesi
howev
strike
one
studi
wt
mice
produc
detect
protein
level
type
ifn
infect
moreov
rigi
mav
mice
infect
chikv
surviv
small
increas
viral
load
sera
tissu
observ
mice
show
slightli
sever
phenotyp
dissemin
chikv
h
post
infect
result
togeth
probabl
indic
sever
prr
involv
sens
chikv
miss
one
receptor
suffici
induc
lethal
phenotyp
seen
ifnar
mice
line
rudd
et
al
show
increas
viremia
mav
mice
moreov
agreement
earlier
studi
show
ifnar
mice
die
sever
patholog
ie
oedema
haemorrhag
shock
addit
rudd
et
al
evalu
influenc
chikungunya
patholog
mice
surviv
chikv
infect
doubleknockout
mice
die
within
day
viral
titr
blood
tissu
significantli
higher
mice
compar
wt
mice
three
group
knockout
mice
diseas
symptom
occur
earlier
sever
compar
wt
mice
furthermor
mous
serum
high
level
proinflammatori
cytokin
detect
found
import
induct
ifn
chikv
infect
lastli
sever
isg
also
shown
influenc
viral
titr
blood
tissu
surviv
differ
knockout
model
conclud
ifn
respons
greatli
influenc
diseas
control
sever
chikv
sens
dominantli
though
adapt
immun
also
shown
contribut
control
chikv
infect
chikv
thought
evad
innat
immun
respons
caus
transcript
translat
shutoff
host
cell
chikungunya
infect
trigger
isg
mrna
product
depend
primari
human
fibroblast
howev
protein
express
infect
illustr
chikv
block
host
cell
translat
therebi
prevent
isg
effector
respons
moreov
studi
show
h
post
infect
transcript
also
effect
inhibit
chikv
thought
involv
mediat
transcript
host
shutoff
although
establish
cell
line
sindbi
viru
rel
chikv
mutant
shown
increas
ifn
product
surviv
infect
mice
consider
increas
exact
mechan
host
translat
shutoff
viral
protein
involv
clear
yet
hamper
investig
role
evas
method
chikungunya
pathogenesi
addit
alphavirus
suggest
directli
inhibit
stat
signal
even
though
investig
experiment
anim
model
yet
recent
chan
et
al
studi
role
nonstructur
protein
mutat
chikv
pathogenesi
mutat
cleavag
site
mutant
call
rh
affect
polyprotein
process
result
reduc
viremia
viru
clear
earlier
blood
caus
reduc
inflamm
also
correl
local
increas
proinflammatori
cytokin
chemokin
level
h
post
infect
second
mutant
substitut
proteas
domain
mutant
ev
actual
show
increas
viremia
joint
inflamm
compar
wt
chikv
doubl
mutant
contain
mutat
mutant
rhev
behav
like
rh
mutant
interestingli
wt
ev
chikv
show
delay
induct
inflammatori
cytokin
chemokin
compar
rh
rhev
viru
post
infect
virus
produc
higher
level
proinflammatori
cytokin
like
rh
rhev
mutant
support
notion
antivir
ifn
respons
affect
diseas
sever
show
dysregul
innat
immun
respons
inflict
viral
immun
evas
activ
might
contribut
patholog
overal
chikv
often
suggest
import
viral
factor
involv
innat
immun
evas
might
thu
major
caus
patholog
though
yet
confirm
vivo
therefor
much
remain
discov
immun
evas
chikv
protein
context
viral
infect
flavivirus
compris
human
pathogen
main
caus
arthropodborn
diseas
review
place
emphasi
denv
recent
emerg
zikv
sinc
current
largest
societ
impact
infect
virus
mainli
asymptomat
dengu
endem
mani
countri
america
southeast
asia
africa
five
distinct
serotyp
denv
clinic
symptom
dengu
includ
fever
skin
rash
headach
sever
case
infect
lead
plasma
leakag
without
haemorrhag
diseas
mostli
selflimit
small
proport
patient
develop
sever
diseas
zikv
preval
america
mild
case
caus
fever
rash
muscl
pain
headach
zikv
caus
neurolog
complic
syndrom
especi
earli
stage
pregnanc
infect
lead
congenit
abnorm
microcephali
zikv
denv
transmit
aed
mosquito
flavivirus
genom
around
kb
contain
termin
cap
lack
poli
tail
figur
genom
encod
one
larg
polyprotein
process
viral
host
proteas
three
structur
protein
e
c
prm
seven
nonstructur
protein
nonstructur
protein
involv
viral
replic
modul
host
respons
structur
protein
compris
compon
assembl
new
viral
particl
ifn
respons
rapidli
upregul
zika
patient
zika
patient
acut
phase
infect
increas
mrna
level
peripher
blood
compar
healthi
control
zikv
infect
also
associ
high
mrna
level
studi
found
viral
load
posit
correl
type
ifn
express
howev
proinflammatori
cytokin
ifnstimul
chemokin
associ
sever
zika
dengu
one
studi
show
zika
patient
moder
symptom
viremia
higher
level
patient
mild
symptom
viremia
also
associ
zikvinfect
women
carri
foetus
congenit
abnorm
dengu
patient
sever
diseas
associ
high
plasma
level
moreov
sever
case
dengu
increas
level
proinflammatori
cytokin
antiinflammatori
cytokin
chemokin
includ
report
cytokin
storm
dengu
patient
lead
plasma
leakag
haemorrhag
seen
sever
dengu
case
implic
immunopatholog
substanti
part
flaviviru
pathogenesi
import
interferon
restrict
denv
zikv
infect
quit
clear
mous
model
sinc
mice
lack
innat
immun
compon
suscept
replic
flavivirus
subcutan
infect
zikv
adult
immunocompet
mice
mice
show
sign
diseas
viral
titr
detect
blood
mice
howev
mice
lack
type
ifn
receptor
show
sign
ill
measur
blood
titr
lethal
mice
shown
agedepend
mice
sever
diseas
observ
anim
succumb
zikv
infect
mice
reduc
mortal
mice
surviv
contrast
dowal
et
al
show
mice
die
zikv
infect
although
differ
might
explain
viru
strain
dosag
threeweekold
mice
defici
type
ii
ifn
signal
also
die
zikv
infect
signific
differ
mortal
rate
weight
loss
organ
viral
titr
found
mice
indic
especi
type
ifn
respons
import
control
zikv
infect
howev
aliota
et
al
show
young
adult
mice
succumb
zikv
infect
might
highlight
role
control
zikv
infect
adult
could
possibl
explain
agedepend
mortal
mice
observ
rossi
et
al
mice
also
succumb
infect
denv
serotyp
though
mice
surviv
infect
mice
dissemin
infect
therefor
contrast
zikv
infect
type
ii
ifn
respons
appear
import
restrict
denv
infect
mice
ifnar
mice
also
die
infect
two
mouseadapt
strain
measur
viral
titr
blood
tissu
block
ifn
receptor
antibodi
mimick
phenotyp
seen
knockout
mice
wildtyp
zikvinfect
mice
treatment
block
antibodi
result
mortal
depend
rout
zikv
inject
induc
sever
neuropatholog
compar
observ
mice
block
antibodi
also
result
detect
viral
titr
blood
variou
tissu
accord
observ
flaviviru
infect
control
also
associ
signal
compon
ifn
pathway
exampl
wildtyp
mice
infect
intravagin
zikv
shown
zikv
abl
replic
lower
femal
reproduct
tract
measur
viral
load
posit
correl
induct
moreov
treatment
mice
acitretin
enhanc
rigi
signal
one
day
prior
infect
induc
type
iii
ifn
proinflammatori
cytokin
inhibit
zikv
replic
lower
femal
reproduct
tract
mice
lack
mav
inocul
zikv
ifnar
irf
tripleknockout
mice
significantli
lost
weight
succumb
diseas
although
percentag
surviv
mice
strain
agedepend
mav
mice
show
morbid
mortal
mice
defici
develop
viremia
wt
mice
mice
defici
mav
trif
dk
infect
zikv
exhibit
sign
diseas
mortal
though
viru
detect
blood
tissu
viral
titr
blood
tissu
highest
dk
mice
addit
higher
viral
load
associ
decreas
type
ifn
product
express
spleen
denvinfect
mice
lack
mav
adapt
mortal
observ
either
though
viremia
detect
delay
decreas
type
ifn
express
blood
spleen
observ
seen
zikvinfect
mice
infect
induc
lethal
stat
balbc
mice
lastli
combin
agonist
shown
protect
rhesu
macaqu
denv
infect
decreas
viremia
though
studi
group
small
result
role
type
ifn
zikv
pathogenesi
pregnanc
conflict
evid
link
type
ifn
protect
placenta
foetu
zikv
exampl
midgest
placenta
larg
resist
zikv
infect
associ
higher
level
express
moreov
studi
effect
zikv
infect
pregnanc
transplacent
transmiss
mous
model
zikv
develop
knock
use
model
protect
harm
effect
ifn
found
cross
ifnar
femal
mice
male
wt
mice
result
ifnar
placenta
foetus
zikv
infect
ifnar
mice
midpregn
result
foetal
demis
caus
reduc
damag
placenta
compar
zikv
infect
foetus
complet
defici
type
ifn
signal
howev
foetus
still
suffer
intrauterin
growth
retard
studi
mainli
suggest
presenc
ifn
signal
foetus
placenta
protect
effect
contrast
pregnant
femal
mice
mate
wt
male
mice
infect
zikv
foetal
demis
occur
major
case
rest
foetus
exhibit
intrauterin
growth
retard
moreov
treat
pregnant
wt
mice
block
antibodi
also
result
growth
retard
although
lesser
extent
foetus
yockey
et
al
addit
show
foetus
undergo
foetal
demis
pregnant
dam
infect
zikv
dam
got
infect
zikv
foetus
show
reduc
intrauterin
growth
retard
compar
foetus
viral
titr
compar
ifnar
placenta
higher
ifnar
placenta
indic
type
ifn
respons
viru
load
respons
sever
diseas
phenotyp
author
also
examin
effect
treatment
recombin
human
chorion
villou
isol
midgest
placenta
treatment
result
abnorm
villou
structur
treatment
influenc
villi
interestingli
huge
differ
gene
induc
two
type
ifn
although
share
signal
pathway
conflict
result
role
ifn
might
partial
explain
differ
embryon
day
analys
howev
clear
role
type
ifn
protect
foetu
zikv
requir
investig
protect
role
type
iii
ifn
restrict
zikv
pregnanc
clearli
identifi
primari
human
placent
trophoblast
shown
resist
zikv
infect
produc
high
basal
level
type
iii
ifn
moreov
two
model
consist
primari
placent
fibroblast
endotheli
cell
cocultur
cell
better
reflect
primari
human
trophoblast
develop
use
model
shown
cell
becam
less
suscept
zikv
express
high
basal
level
isg
addit
human
placent
villi
isol
secondtrimest
placenta
mostli
resist
zikv
infect
also
capabl
produc
furthermor
evid
mice
model
also
support
protect
role
type
iii
ifn
mice
defici
mate
pregnant
dam
infect
zikv
embryon
day
pretreat
antibodi
block
allow
transplacent
transmiss
zikv
titr
placenta
foetal
head
higher
mice
foetus
wt
mice
interestingli
placenta
foetus
zikv
titr
compar
wt
mice
indic
type
iii
ifn
placenta
foetu
suffici
control
zikv
support
fact
pegyl
mous
treatment
wt
mice
pretreat
block
antibodi
infect
zikv
present
reduc
zikv
titr
placenta
foetal
head
furthermor
isol
human
chorion
villi
foetal
membran
decidua
basali
respond
treatment
induc
isg
reduc
zikv
titr
second
studi
also
show
benefici
effect
treatment
treat
zikvinfect
ifnar
pregnant
mice
type
iii
ifn
prevent
foetal
demis
improv
foetal
growth
addit
zikv
titr
reduc
matern
foetal
organ
studi
found
benefici
effect
treatment
earli
pregnanc
administ
particular
nsp
flavivirus
consid
antagonist
host
innat
immun
denv
shown
increas
pathogenesi
mice
subleth
dose
combin
recombin
result
lethal
ifnar
mice
shown
induc
vascular
leakag
moreov
mice
vaccin
week
later
challeng
lethal
dose
none
mice
die
howev
sinc
result
obtain
ifnar
mice
link
innat
immun
evas
establish
immunocompromis
mous
model
current
use
alway
limit
studi
address
dengu
pathogenesi
context
innat
immun
therefor
develop
adequ
anim
model
desir
denv
thought
inhibit
ifn
signal
degrad
interestingli
shown
confer
host
specif
exampl
inhibit
mous
sever
cell
line
suggest
one
main
reason
denv
abl
replic
immunocompet
mice
hypothesi
support
fact
mice
led
delay
clearanc
denv
mous
model
human
might
thu
interest
studi
effect
possibl
immun
evas
mechan
dengu
pathogenesi
flaviviru
complex
serv
proteas
cleav
human
sting
vitro
therebi
thought
inhibit
antivir
immun
respons
support
viral
replic
howev
mice
defici
sting
respond
differ
zikv
infect
wildtyp
mice
also
make
less
like
affect
zika
pathogenesi
action
sting
howev
might
still
target
signal
molecul
interfer
innat
immun
respons
anoth
studi
show
inflammasom
decreas
ifn
respons
support
viral
replic
establish
use
neonat
mice
play
role
inflammasom
activ
inject
zikv
brain
knockout
mice
show
higher
express
lower
viral
titr
brain
gain
weight
wt
mice
human
peripher
mononuclear
blood
cell
also
shown
inhibit
increas
express
studi
show
activ
inflammasom
cell
line
togeth
data
suggest
zikv
might
abl
support
viral
replic
activ
inflammasom
need
confirm
xia
et
al
discov
zikv
suppress
vitro
depend
zikv
strain
abl
suppress
contrast
one
amino
acid
differ
two
strain
ie
substitut
substitut
shown
respons
suppress
express
bone
marrowderiv
dendrit
cell
bmdc
isol
mice
moreov
xia
et
al
infect
mice
two
strain
zikv
two
mutant
virus
virus
alanin
posit
show
consider
higher
level
sera
infect
anim
howev
surviv
neonat
mice
infect
mutant
viru
significantli
differ
compar
surviv
wtinfect
mice
suggest
effect
alon
signific
contributor
pathogenesi
zikv
author
demonstr
abl
suppress
vitro
leav
mani
potenti
candid
investig
virul
zikv
although
ifn
respons
regard
first
line
defenc
virus
role
pathogenesi
viral
infect
doublesid
one
hand
mani
ssrna
virus
develop
mechan
antagon
ifn
respons
protect
antivir
effect
without
proper
immun
respons
restrict
viru
replic
infect
well
diseas
might
progress
hand
viral
evas
often
caus
delay
hyperinduc
ifn
inflammatori
respons
shown
caus
patholog
anim
model
help
us
assess
function
immun
evas
viral
protein
context
viru
infect
clinic
outcom
conflict
result
link
ifn
pathway
viral
pathogenesi
remain
probabl
emphas
ambigu
role
innat
immun
respons
pathogenesi
overal
studi
conclud
balanc
correct
time
ifn
respons
seem
import
control
diseas
sever
also
import
type
iii
ifn
control
viru
infect
becom
evid
discuss
zikv
elucid
role
type
iii
ifn
viral
infect
thu
great
interest
especi
virus
target
mucos
surfac
merscov
moreov
gain
knowledg
interact
innat
immun
viral
infect
includ
activ
viral
immun
evas
protein
possibl
develop
novel
treatment
prevent
strategi
might
appear
horizon
